Blog

IONIQ Sciences / News  / IONIQ Sciences hires Edison Group as Investor Relations Advisor

IONIQ Sciences hires Edison Group as Investor Relations Advisor

Salt Lake City, UT, March 17, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that it has hired Edison Group, a leading investor relations and research firm, to assist with its investor relations program. Edison Group, established in 2003, is an investor relations, investor research, and consulting firm. With broad sector knowledge, analyst resources and deep capital markets expertise, Edison’s team will enhance IONIQ’s communications strategy and broaden its investor awareness and engagement.

Mr. Jared Bauer, IONIQ’s CEO, stated, “We are excited to team up with the Edison Group to enhance and amplify how we communicate our continuing progress to modernize early-stage cancer detection to the life science institutional market. The Edison Group’s deeply experienced communications team and strong investor networks will allow us to engage with new potential investors.”

 

About IONIQ Sciences, Inc.
IONIQ Sciences, Inc. is developing an advanced multi-cancer screening technology for early detection that has the potential to expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare. IONIQ Sciences operates at the confluence of its Electrical Impedance Analytics (EIA) or bioimpedance technology and Artificial Intelligence (AI). IONIQ Science’s first product utilizing its proprietary analytic platform, the IONIQ ProLung Test™ for lung cancer, has been designated a Breakthrough Device by the U.S. FDA. For more information visit: www.IONIQsciences.com

 

About BioHive

IONIQ Sciences is proud to be a key supporter and member of the newly formed BioHive, a collective representing the life science and healthcare innovation ecosystem. By embracing diversity and collaboration, BioHive has become the fastest-growing life science community in America and their innovations are improving the lives of millions of patients. To learn more, visit: www.biohive.com

 

About Edison Group

Edison Group is an investment research, investor relations, and consulting firm. Edison’s leading research and investor relations consultancy connects listed companies to the widest pool of global investors. By focusing on both the volume and quality of investors reached – across institutions, family offices, wealth managers and retail investors, Edison can create and gauge intent to purchase, even in the darkest pools of capital. For more information visit: www.edisongroup.com

For further information about IONIQ Sciences, Inc., please contact:
Andy Robertson | 1-801-736-0729 | acr@IONIQsciences.com
IONIQ Sciences, Vice President of Business Development

IONIQ Sciences, Inc.
350 W. 800 N., Suite 214
Salt Lake City, Utah 84103
USA
www.IONIQsciences.com

 

Edison Group Contact:
Alyssa Factor | ioniq@edisongroup.com